These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

592 related items for PubMed ID: 27007128

  • 21. Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and 18F-FDG PET/CT for radiotherapy target volume definition.
    Guberina M, Darwiche K, Hautzel H, Pöttgen C, Guberina N, Gauler T, Ploenes T, Umutlu L, Theegarten D, Aigner C, Eberhardt WEE, Metzenmacher M, Wiesweg M, Karpf-Wissel R, Schuler M, Herrmann K, Stuschke M.
    Radiat Oncol; 2021 Sep 15; 16(1):176. PubMed ID: 34526050
    [Abstract] [Full Text] [Related]

  • 22. 18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense?
    Hellwig D, Graeter TP, Ukena D, Groeschel A, Sybrecht GW, Schaefers HJ, Kirsch CM.
    J Nucl Med; 2007 Nov 15; 48(11):1761-6. PubMed ID: 17942814
    [Abstract] [Full Text] [Related]

  • 23. Diagnostic accuracy of lymph node metastasis depends on metabolic activity of the primary lesion in thoracic squamous esophageal cancer.
    Manabe O, Hattori N, Hirata K, Itoh K, Hosokawa M, Takahashi H, Oyama-Manabe N, Tamaki N.
    J Nucl Med; 2013 May 15; 54(5):670-6. PubMed ID: 23516310
    [Abstract] [Full Text] [Related]

  • 24. Node/aorta and node/liver SUV ratios from (18)F-FDG PET/CT may improve the detection of occult mediastinal lymph node metastases in patients with non-small cell lung carcinoma.
    Kuo WH, Wu YC, Wu CY, Ho KC, Chiu PH, Wang CW, Chang CJ, Yu CT, Yen TC, Lin C.
    Acad Radiol; 2012 Jun 15; 19(6):685-92. PubMed ID: 22459646
    [Abstract] [Full Text] [Related]

  • 25. Mediastinal lymph nodes staging by 18F-FDG PET/CT for early stage non-small cell lung cancer: a multicenter study.
    Li X, Zhang H, Xing L, Ma H, Xie P, Zhang L, Xu X, Yue J, Sun X, Hu X, Chen M, Xu W, Chen L, Yu J.
    Radiother Oncol; 2012 Feb 15; 102(2):246-50. PubMed ID: 22100657
    [Abstract] [Full Text] [Related]

  • 26. Preliminary clinical assessment of dynamic 18F-fluorodeoxyglucose positron emission tomography/computed tomography for evaluating lymph node metastasis in patients with lung cancer: a prospective study.
    Shinya T, Otomi Y, Kubo M, Kinoshita M, Takechi K, Uyama N, Yamanaka M, Terazawa K, Toba H, Bando Y, Otsuka H, Harada M.
    Ann Nucl Med; 2019 Jun 15; 33(6):414-423. PubMed ID: 30911883
    [Abstract] [Full Text] [Related]

  • 27. Pelvic Lymph Node Staging by Combined 18F-FDG-PET/CT Imaging in Bladder Cancer Prior to Radical Cystectomy.
    Pichler R, De Zordo T, Fritz J, Kroiss A, Aigner F, Heidegger I, Virgolini I, Horninger W, Uprimny C.
    Clin Genitourin Cancer; 2017 Jun 15; 15(3):e387-e395. PubMed ID: 27601364
    [Abstract] [Full Text] [Related]

  • 28. Accuracy of F-18 FDG PET/CT with optimal cut-offs of maximum standardized uptake value according to size for diagnosis of regional lymph node metastasis in patients with rectal cancer.
    Bae SU, Won KS, Song BI, Jeong WK, Baek SK, Kim HW.
    Cancer Imaging; 2018 Sep 14; 18(1):32. PubMed ID: 30217167
    [Abstract] [Full Text] [Related]

  • 29. Occult mediastinal lymph node metastasis in NSCLC patients diagnosed as clinical N0-1 by preoperative integrated FDG-PET/CT and CT: Risk factors, pattern, and histopathological study.
    Kanzaki R, Higashiyama M, Fujiwara A, Tokunaga T, Maeda J, Okami J, Kozuka T, Hosoki T, Hasegawa Y, Takami M, Tomita Y, Kodama K.
    Lung Cancer; 2011 Mar 14; 71(3):333-7. PubMed ID: 20619479
    [Abstract] [Full Text] [Related]

  • 30. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
    Billé A, Pelosi E, Skanjeti A, Arena V, Errico L, Borasio P, Mancini M, Ardissone F.
    Eur J Cardiothorac Surg; 2009 Sep 14; 36(3):440-5. PubMed ID: 19464906
    [Abstract] [Full Text] [Related]

  • 31. A Pilot Study of 18F-Alfatide PET/CT Imaging for Detecting Lymph Node Metastases in Patients with Non-Small Cell Lung Cancer.
    Zhou Y, Gao S, Huang Y, Zheng J, Dong Y, Zhang B, Zhao S, Lu H, Liu Z, Yu J, Yuan S.
    Sci Rep; 2017 Jun 06; 7(1):2877. PubMed ID: 28588317
    [Abstract] [Full Text] [Related]

  • 32. Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F-FDG PET/CT in a tuberculosis-endemic country: diagnostic efficacy in 674 patients.
    Kim YK, Lee KS, Kim BT, Choi JY, Kim H, Kwon OJ, Shim YM, Yi CA, Kim HY, Chung MJ.
    Cancer; 2007 Mar 15; 109(6):1068-77. PubMed ID: 17311309
    [Abstract] [Full Text] [Related]

  • 33. A machine learning tool to improve prediction of mediastinal lymph node metastases in non-small cell lung cancer using routinely obtainable [18F]FDG-PET/CT parameters.
    Rogasch JMM, Michaels L, Baumgärtner GL, Frost N, Rückert JC, Neudecker J, Ochsenreither S, Gerhold M, Schmidt B, Schneider P, Amthauer H, Furth C, Penzkofer T.
    Eur J Nucl Med Mol Imaging; 2023 Jun 15; 50(7):2140-2151. PubMed ID: 36820890
    [Abstract] [Full Text] [Related]

  • 34. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
    Yoo IeR, Chung SK, Park HL, Choi WH, Kim YK, Lee KY, Wang YP.
    Biomed Mater Eng; 2014 Jun 15; 24(6):3091-103. PubMed ID: 25227018
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Risk factors for mediastinal lymph node metastasis in non-small-cell lung cancer by PET/CT.
    Xu ZQ, Xie LJ, Fan W, Duan XB, Cheng MH.
    Nucl Med Commun; 2014 May 15; 35(5):466-71. PubMed ID: 24535381
    [Abstract] [Full Text] [Related]

  • 37. Impact of mediastinal tumor burden and lymphatic spread in locally advanced non-small-cell lung cancer: A secondary analysis of the multicenter randomized PET-Plan trial.
    Gkika E, Dejonckheere CS, Sahlmann J, Barth SA, Schimek-Jasch T, Adebahr S, Hecht M, Miederer M, Brose A, Binder H, König J, Grosu AL, Nestle U, Rimner A.
    Radiother Oncol; 2024 Nov 15; 200():110521. PubMed ID: 39236984
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Preoperative evaluation of mediastinal lymph nodes in non-small cell lung cancer using [68Ga]FAPI-46 PET/CT: a prospective pilot study.
    Kang YK, Na KJ, Park J, Kwak N, Lee YS, Choi H, Kim YT.
    Eur J Nucl Med Mol Imaging; 2024 Jul 15; 51(8):2409-2419. PubMed ID: 38451308
    [Abstract] [Full Text] [Related]

  • 40. FDG-PET/CT for pretherapeutic lymph node staging in non-small cell lung cancer: A tailored approach to the ESTS/ESMO guideline workflow.
    Rogasch JMM, Frost N, Bluemel S, Michaels L, Penzkofer T, von Laffert M, Temmesfeld-Wollbrück B, Neudecker J, Rückert JC, Ochsenreither S, Böhmer D, Amthauer H, Furth C.
    Lung Cancer; 2021 Jul 15; 157():66-74. PubMed ID: 33994197
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.